Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases

NCT ID: NCT02260323

Last Updated: 2017-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the compliance of traditional Chinese medicine (TCM) in young people with Chronic rheumatic disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Rheumatic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patient-tailored anti-arthritis herbs

patient use tailored anti-arthritis herbs

Group Type EXPERIMENTAL

patient-tailored anti-arthritis herbs

Intervention Type OTHER

patient use tailored anti-arthritis herbs

patient-tailored DMARDs

Patients use tailored DMARDs

Group Type ACTIVE_COMPARATOR

patient-tailored DMARDs

Intervention Type OTHER

patient use tailored disease-modifying antirheumatic drugs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

patient-tailored anti-arthritis herbs

patient use tailored anti-arthritis herbs

Intervention Type OTHER

patient-tailored DMARDs

patient use tailored disease-modifying antirheumatic drugs

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

patient-tailored disease-modifying antirheumatic drugs

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* were between 18 and 35 years of age
* without use of TCM in the previous 3 months
* and had a Steinbrocker functional status of class I, II, or III

Exclusion Criteria

* previous general health conditions disallowed their use of TCM
* were pregnant
* lack of motivation, remote from home, time-consuming,intervention, or other personal difficulties
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chengdu PLA General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yang Min

Ph.D

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

General Hospital of Chengdu Military Area Command PLA

Chengdu, Sichuan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CT20141003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.